FGFR2 and endometrial cancer: In conclusion, our mutation analysis of four oncogenes frequently mutated in the endometrioid histology of endometrial cancer revealed that mutated FGFR2 was associated with shorter disease free progression and this was significant in patients diagnosed with early stage disease.